Shah Duru, Jirge Padma Rekha
Gynaecworld, The Centre for Women's Health and Fertility, Mumbai, Maharashtra, India.
Sushrut Assisted Conception Clinic, Shreyas Hospital, Kolhapur, Maharashtra, India.
J Hum Reprod Sci. 2024 Jan-Mar;17(1):16-24. doi: 10.4103/jhrs.jhrs_153_23. Epub 2024 Mar 28.
Anti-Mullerian hormone is a robust marker of ovarian reserve and ovarian response in fertilisation (IVF). However, its role extends beyond improving the safety of IVF by aiding in choosing appropriate protocols and dosing. This review looks at the value of pre-treatment anti-Mullerian hormone (AMH) value in choosing the appropriate modality of treatment and its predictive ability for the outcomes of such treatment. It briefly addresses the factors that may modulate AMH levels and make clinical decision-making challenging.
抗苗勒管激素是体外受精（IVF）中卵巢储备和卵巢反应的一个可靠标志物。然而，其作用不仅限于通过辅助选择合适的方案和剂量来提高体外受精的安全性。本综述探讨了治疗前抗苗勒管激素（AMH）值在选择合适治疗方式方面的价值及其对这类治疗结果的预测能力。它简要讨论了可能调节AMH水平并给临床决策带来挑战的因素。
Zotero 插件